Reference
Scottish Medicines Consortium. SMC advice: aclidinium/formoterol fumarate dihydrate (Duaklir Genuair); fingolimod (Gilenya); levonorgestrel (Jaydess); nintedanib (Vargatef); ponatinib (Iclusig); regorafenib (Stivarga); sucroferric oxyhydroxide (Velphoro); tacrolimus (Envarsus). Internet Document : 13 Apr 2015. Available from: URL: http://www.scottishmedicines.org.uk/Home
Rights and permissions
About this article
Cite this article
Three cancer treatments accepted for use by SMC. PharmacoEcon Outcomes News 726, 35 (2015). https://doi.org/10.1007/s40274-015-2083-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2083-0